Literature DB >> 1105021

The use of differential skin-temperature measurements in the evaluation of post-traumatic oedema control.

H J Hambury, J Watson, A Toole.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1105021     DOI: 10.1007/bf02477729

Source DB:  PubMed          Journal:  Med Biol Eng        ISSN: 0025-696X


× No keyword cloud information.
  9 in total

1.  TISSUE PEPTIDASE ACTIVITY FOLLOWING ORALLY GIVEN PROTEASES.

Authors:  I INNERFIELD; F S GIMBLE; E BLINCOE
Journal:  Life Sci (1962)       Date:  1964-03

2.  The chemistry of local dermal inflammation.

Authors:  J C HOUCK; R A JACOB
Journal:  J Invest Dermatol       Date:  1961-06       Impact factor: 8.551

3.  Changes in serum trypsin inhibitors induced by the administration of proteolytic enzyme tablets to surgical patients.

Authors:  G Margetts; K Barber; R B Christie; W E Jones; W T Bowden
Journal:  Br J Clin Pract       Date:  1972-06

4.  Trial of Chymoral in professional footballers.

Authors:  J E Buck; N Phillips
Journal:  Br J Clin Pract       Date:  1970-09

5.  The use of a trypsin-chymotrypsin formulation in fractures of the hand.

Authors:  P C Shaw
Journal:  Br J Clin Pract       Date:  1969-01-01

6.  Evaluation of an oral proteolytic enzyme in operations upon the hand.

Authors:  K K Lie; R D Larsen; J L Posch
Journal:  Surg Gynecol Obstet       Date:  1967-09

7.  Intestinal plasminogen proactivator and activator after oral administration of proteolytic enzymes.

Authors:  M Nakahara; T Kawamura; S Itaya
Journal:  Arzneimittelforschung       Date:  1967-07

8.  Effect of intestinal pronase administration on plasminogen activator in intestinal mucosa.

Authors:  M Nakahara
Journal:  Pharmacology       Date:  1971       Impact factor: 2.547

9.  Oral proteolytic enzyme therapy (chymoral) in episiotomy patients.

Authors:  S D Soule; H C Wasserman; R Burstein
Journal:  Am J Obstet Gynecol       Date:  1966-07-15       Impact factor: 8.661

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.